Agile Therapeutics, Inc.
USD1.51
+0.05 (+3.42%)
CEO
Alfred F. Altomari
IPO Date
2014-05-23
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$1.48
Prev. Close
$1.46
Day Low
$1.44
Day High
$1.51
52W Low
$0.20
52W High
$2.63
Market Cap
$0.01B
Volume
0.12M
| -0.2 |
| 31 Dec 2021 | FY | -161.4% | -1867.5% | -826.1% | -194.7% | 1.94 | 0.82 | -0.0 |
| 31 Dec 2020 | FY | 62.3% | -7301.2% | -110.9% | -74.8% | 0.33 | 7.72 | -4.4 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -40.3% | -37.2% | 0.00 | 9.31 | -6.7 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -98.0% | -88.3% | 0.00 | 3.81 | -1.0 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -77.9% | -55.9% | 0.29 | 2.57 | -2.9 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -68.0% | -45.0% | 0.38 | 4.82 | -5.6 |
| 31 Dec 2015 | FY | 0.0% | 0.0% | -102.0% | -59.8% | 0.52 | 4.80 | -7.1 |
| 31 Dec 2014 | FY | 0.0% | 0.0% | -44.7% | -29.3% | 0.41 | 4.56 | -4.4 |
| 0.2 |
| 31 Dec 2023 | Q4 | 39.4% | -123.7% | 27.4% | -43.6% | -0.13 | 0.46 | -0.3 |
| 30 Sept 2023 | Q3 | 62.8% | -12.0% | 6.4% | -7.3% | -0.23 | 0.57 | -2.2 |
| 30 Jun 2023 | Q2 | 58.1% | -69.2% | 31.4% | -30.3% | -0.22 | 0.76 | -0.3 |
| 31 Mar 2023 | Q1 | 47.5% | -94.7% | 38.3% | -26.4% | -0.27 | 0.59 | -0.7 |
| 31 Dec 2022 | Q4 | 58.6% | -332.3% | 239.5% | -93.2% | -0.40 | 0.85 | -0.2 |
| 30 Sept 2022 | Q3 | 52.5% | -734.5% | -352.2% | -119.4% | 0.39 | 1.33 | -0.1 |
| 30 Jun 2022 | Q2 | -4.9% | -574.7% | -357.4% | -37.2% | 3.95 | 0.64 | -0.1 |
| 31 Mar 2022 | Q1 | 13.3% | -668.3% | -429.1% | -40.2% | 4.89 | 0.56 | -0.6 |